News

Filter

Current filters:

BiotechnologyReproductive

1 to 9 of 11 results

ViroPharma gets FDA backing for industrial scale Cinryze manufacturing

07-08-2012

US biotech firm ViroPharma (Nasdaq: VPHM) says that the US Food and Drug Administration has approved…

BiotechnologyCinryzeNorth AmericaProductionRegulationReproductiveViroPharma

In Japan, AstraZeneca to co-promote denosumab with Daiichi; Sosei debuts NorLevo

24-05-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) today announced a co-promotion agreement in Japan with…

Asia-PacificAstraZenecaBiotechnologyDaiichi SankyodenosumabMarkets & MarketingNorLevoOncologyPharmaceuticalReproductiveSoseiXgeva

Shionogi gains global marketing rights to QuatRx’ ospemifene in up to $125 million deal; Astellas sues OSI over acquisition plan

03-03-2010

Japanese drug major Shionogi has entered into a worldwide license agreement to develop and market ospemifene,…

BiotechnologyLicensingMergers & AcquisitionsPharmaceuticalReproductiveShionogi

Pharmaceutical sales in Romania continued to show strong growth in 2009

25-01-2010

In its Business Environment Rating matrix for first-quarter 2010, Business Monitor International said…

Antibiotics and Infectious diseasesBiotechnologyCarvedilolCialisCoregEuropeMarkets & MarketingOncologyPharmaceuticalReproductiveRochesildenafilTadalafilViagra

Newer therapies to treat lifestyle disorders and reduce co-morbidities risk key to expansion of sectors’ European market, says F&S

03-12-2009

Increasing genomic knowledge will lead to the development of improved therapies to treat lifestyle disorders.…

BiotechnologyDrug DiscoveryEuropeGeneralMarkets & MarketingMetabolicsPharmaceuticalReproductive

1 to 9 of 11 results

COMPANY SPOTLIGHT

Menarini

Back to top